663620-70-0 Usage
Description
2-[[1-[7-Methyl-2-(morpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid is a complex organic compound with a molecular formula C23H25N5O4. It is a synthetic derivative of pyrimidine and benzene, featuring a benzene ring with a carboxylic acid group, a pyrimidine ring, and a morpholine ring. 2-[[1-[7-Methyl-2-(morpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid holds potential pharmaceutical applications due to its structural similarity to certain biologically active compounds. Preliminary studies suggest it may possess anti-cancer, anti-inflammatory, or other therapeutic properties, although further research is required to ascertain its precise pharmacological potential.
Uses
Used in Pharmaceutical Industry:
2-[[1-[7-Methyl-2-(morpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid is used as a potential therapeutic agent for its possible anti-cancer properties, given its structural resemblance to biologically active compounds. It is being investigated for its potential to target and inhibit the growth of cancer cells, thereby serving as a candidate for cancer treatment.
Used in Research and Development:
In the field of medicinal chemistry, this compound is utilized as a research tool to explore its anti-inflammatory and other therapeutic effects. It aids scientists in understanding the mechanisms of action and potential interactions with biological targets, which is crucial for the development of new drugs and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 663620-70-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,3,6,2 and 0 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 663620-70:
(8*6)+(7*6)+(6*3)+(5*6)+(4*2)+(3*0)+(2*7)+(1*0)=160
160 % 10 = 0
So 663620-70-0 is a valid CAS Registry Number.
663620-70-0Relevant articles and documents
Enantiomerically Pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-A]pyrimidin-9-yl)ethylamino]benzoic Acid, Its Use In Medical Therapy, And A Pharmaceutical Composition Comprising It - 026
-
Page/Page column 7, (2009/08/14)
The present invention relates to enantiomerically pure (?) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid or pharmaceutically acceptable salts thereof, it being in a solid state, its use in medical therapy,